https://doctransparency.com/doctor/tx/houston/manish-patel-1942453071
Medicare Enrolled

Dr. Manish Patel, M.D

Surgery · Houston, TX
Low-engagement
6400 FANNIN ST STE 2350, Houston, TX 77030
7134866710
In practice since 2008 (17 years)
NPI: 1942453071 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Patel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Patel? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Patel

Dr. Manish Patel is a surgery in Houston, TX, with 17 years in practice.

Between the years covered by Open Payments, Dr. Patel received a total of $17,183 from 27 pharmaceutical and/or device companies across 131 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in surgery. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Patel is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice$ $17,183 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$17,183
Total received (2018-2024)
Avg $2,455/year across 7 years
Top 17% in TX for surgery
27
Companies
131
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,991 (64.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$6,192 (36.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$689
2023
$3,190
2022
$5,895
2021
$643
2020
$1,842
2019
$2,236
2018
$2,689

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$9,472
TransMedics, Inc.
$2,081
ABIOMED
$1,587
Medtronic Vascular, Inc.
$1,308
Edwards Lifesciences Corporation
$405
AtriCure, Inc.
$400
BAXTER HEALTHCARE
$282
HELIOS CARDIO INC
$248
Medtronic, Inc.
$165
BOSTON SCIENTIFIC CORPORATION
$164
ATRICURE, INC.
$164
Ethicon US, LLC
$129
Chiesi USA, Inc.
$115
Boston Scientific Corporation
$108
Gilead Sciences, Inc.
$102
Amgen Inc.
$80
Wound Management Technologies, Inc
$78
LivaNova USA, Inc.
$66
OptiNose US, Inc.
$47
Smith+Nephew, Inc.
$47
Integra LifeSciences Corporation
$29
AngioDynamics, Inc.
$24
Olympus America Inc.
$20
Otsuka America Pharmaceutical, Inc.
$20
United Therapeutics Corporation
$16
Janssen Pharmaceuticals, Inc
$14
iRhythm Technologies, Inc.
$11
Top 3 companies account for 76.5% of total payments
Associated products mentioned in payments ›
1.8mm OD · ACCENT · ADVISOR · AGILIS HISPRO · ATRICLIP LAA EXCLUSION SYSTEM · ATRICURE CRYOICE CRYOABLATION SYSTEM (CRYO2) · AVEIR · Advisor Catheter · Agilis NxT EP Introducer · Always-On Tip Tracked Forceps · Angio-Seal Vascular Closure Dev · AtriCure AtriClip LAA Exclusion System · BIOSENTRY TRACT SEALANT SYSTEM · CARDIAMEND · CARDIOMEMS · CLEVIPREX · COLLAGENASE SANTYL · COSEAL · CYTAL · CardioMEMS HF System · CellerateRx · DERMABOND Portfolio · ECHELON ENDOPATH · EDWARDS INTUITY Elite valve system · EMBLEM · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · Epi-Sense Guided Coagulation System with VisiTrax · FLOSEAL · GENERAL STRUCTURAL HEART · HeartMate · HeartMate 3 Left Ventricular Assist Device · HeartMate 3 Left Ventricular Dev · HeartMate II LVAS · HeartMate Touch · HeartWare HVAD · INGEVITY · INSPIRIS RESILIA AORTIC VALVE · INSPIRIS RESILIA aortic valve · Impella · JYNARQUE · MERLIN@HOME · MITRACLIP · Models · Organ Care System · PICO · PROLENE · Perceval · Perclose ProGlide suture mediated closure system · Quadra Assura CRT Defibrillator · REMODULIN · RESONATE · RHYTHMIA · Ranexa · Repatha · SYNERGY ABLATION SYSTEM · Santyl · Serrated Cup · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · Tendyne Mitral Valve System · WATCHMAN · XARELTO · Xhance · ZIO Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (64%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a surgery in Houston?
Compare surgerys in the Houston area by procedure volume, costs, and industry payment transparency.
Browse surgerys nearby

Geographic Context

Surgerys within 10 mi
525
Per 100K population
11.0
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN - TEXAS MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data— No dataN/A
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Patel is a surgery, and high industry engagement (low-engagement, top 17%), with 17 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Patel receive payments from pharmaceutical companies?
Yes. Dr. Patel received a total of $17,183 from 27 companies across 131 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Patel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →